Is Big Pharma making Money at Pfizer?
To clarify, classic value investors look for cash rich companies that are unpopular and unfashionable. As a pharmaceutical house in 2019, Pfizer Inc. (NYSE: PFE) is both.
Read MoreIn individuals, insanity is rare; but in groups, parties, nations and epochs, it is the rule. Friedrich Nietzsche
To clarify, classic value investors look for cash rich companies that are unpopular and unfashionable. As a pharmaceutical house in 2019, Pfizer Inc. (NYSE: PFE) is both.
Read More